|
C5ORF13 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.179200E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.523540E-03 |
| Normal-vs-Stage2 |
4.043400E-01 |
| Normal-vs-Stage3 |
9.099100E-03 |
| Normal-vs-Stage4 |
3.412600E-01 |
| Stage1-vs-Stage2 |
2.392000E-01 |
| Stage1-vs-Stage3 |
4.595400E-01 |
| Stage1-vs-Stage4 |
8.448200E-01 |
| Stage2-vs-Stage3 |
1.017000E-01 |
| Stage2-vs-Stage4 |
4.960200E-01 |
| Stage3-vs-Stage4 |
9.293600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.735470E-03 |
| Normal-vs-AfricanAmerican |
5.220400E-03 |
| Normal-vs-Asian |
5.345200E-01 |
| Caucasian-vs-AfricanAmerican |
9.109200E-01 |
| Caucasian-vs-Asian |
6.061200E-01 |
| AfricanAmerican-vs-Asian |
4.992600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.611800E-04 |
| Normal-vs-Female |
5.000000E-02 |
| Male-vs-Female |
2.921800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.661000E-01 |
| Normal-vs-Extreme_Weight |
2.823000E-03 |
| Normal-vs-Obese |
3.099100E-03 |
| Normal-vs-Extreme_Obese |
1.729620E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.123600E-01 |
| Normal_Weight-vs-Obese |
2.797000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.682200E-01 |
| Extreme_Weight-vs-Obese |
7.671800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.704600E-01 |
| Obese-vs-Extreme_Obese |
5.660600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.420370E-02 |
| Normal-vs-Age(41-60Yrs) |
3.86230000000154E-05 |
| Normal-vs-Age(61-80Yrs) |
9.560400E-02 |
| Normal-vs-Age(81-100Yrs) |
3.231000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.564600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.495600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.116200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.580600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.163000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.427800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.89150000007699E-07 |
| Normal-VS-Type2 PRCC |
9.143000E-01 |
| Normal-VS-KIRP CIMP |
4.854200E-01 |
| Normal-VS-Unclassified PRCC |
2.358100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.5432399999904E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.565650E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.020000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.263600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.299700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.099640E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.898330E-02 |
| Normal-vs-N1 |
3.888000E-02 |
| Normal-vs-N2 |
5.362400E-01 |
| N0-vs-N1 |
4.682800E-01 |
| N0-vs-N2 |
9.679200E-01 |
| N1-vs-N2 |
7.505000E-01 |
|
|
